An Observational Study of Epoetin Beta [Neorecormon] to Evaluate the Quality of Life in Patients on Dialysis With Chronic Renal Anemia

This multicenter, prospective, observational study will evaluate the quality of life and the factors that influence the quality of life of epoetin beta [Neorecormon] in patients with renal chronic anemia, who are on dialysis. For each eligible patient data will be collected for 6 months. Target sample size is 5000-7000 patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anemia Hematologic Diseases Hemic and Lymphatic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Casablanca, 20000, Morocco

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adult patients >/=18 years of age
Dialysis patients with chronic renal anemia
Written informed consent

Exclusion criteria

Red blood cell transfusion in the previous 2 months
Severe neuropsychological disorder
Diabetic patients with serious complications

This trial is being conducted in Morocco.

Treatment and study plan

epoetin beta [NeoRecormon]

Drug

As prescribed by physician

Primary outcomes

Quality of life assessment: Kidney Disease Quality of Life Questionnaire

Time frame: Throughout study: 6 months

Secondary outcomes

Evaluation of factors (demographic and social characteristics, dialysis method) influencing the quality of life

Time frame: Throughout study: 6 months

Sponsors and collaborators

Lead sponsor

Hoffmann-La Roche

Industry

Registry information

Official study title

Prospective Study Evaluating the Quality of Life in Dialysis Patients With End Stage Renal Disease

Important dates

Study start: 2008
Primary completion: 2012
Study completion: 2012
First posted: Apr 16, 2010
Registry last updated: Sep 13, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed